Investment Partners Asset Management Inc. Sells 185 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Investment Partners Asset Management Inc. trimmed its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 10.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 1,645 shares of the financial services provider’s stock after selling 185 shares during the period. Investment Partners Asset Management Inc.’s holdings in iShares Biotechnology ETF were worth $217,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of IBB. BNP Paribas Financial Markets raised its holdings in shares of iShares Biotechnology ETF by 29.3% during the third quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock valued at $346,561,000 after purchasing an additional 538,899 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund grew its position in iShares Biotechnology ETF by 32.9% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock worth $96,533,000 after purchasing an additional 164,000 shares during the period. Aprio Wealth Management LLC purchased a new stake in iShares Biotechnology ETF during the 4th quarter valued at $18,476,000. DRW Securities LLC bought a new position in shares of iShares Biotechnology ETF during the 3rd quarter valued at $5,990,000. Finally, Erste Asset Management GmbH bought a new position in shares of iShares Biotechnology ETF during the 3rd quarter valued at $5,678,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Up 0.9 %

Shares of IBB opened at $135.47 on Thursday. The business has a fifty day moving average of $135.88 and a 200 day moving average of $141.13. iShares Biotechnology ETF has a one year low of $123.60 and a one year high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were paid a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.